The assignee ranking shows a clearly concentrated top: the leading assignee holds 103 records, and the top five assignees combined account for 42.9% of all 734 records in scope. That concentration extends to the top 10, which together hold 61.9% of all records. Below that group the ranking runs to 100 companies with a long tail of firms holding far fewer filings each, so a freedom-to-operate review should prioritise the concentrated leaders before working down the tail.

Filing activity grew from 39 records in 2017 to a peak of 101 in 2023, then declined to 22 by 2024, a -41% move from 2021's 37 records. However, publication lags filing by roughly 18 months, so the 2025 and 2026 figures in any trend chart are undercounts still filling in. Treat 2024 as the most recent year that can be read as a complete data point, and avoid concluding the field is slowing based on the two most recent years alone.

Beyond the core bioreactor classification, which by definition covers 100% of the 734 records, the next most common overlapping class is C12N microorganism and genetic engineering at 23.3% of records, followed by C07K peptide and protein claims at 10.1% and C12P fermentation claims at 9.7%. Mixing and stirring apparatus (B01F) and separation processes (B01D) trail well behind at 9.4% and 2.9% respectively. Since a single record can carry several IPC classes, these shares add up to more than 100% and should not be read as a breakdown of the whole.

The clearest signal is the gap between the near-universal coverage of the core bioreactor classification and the much lower shares carried by mixing (B01F, 9.4%) and separation (B01D, 2.9%) classes. That gap suggests vessel-integrated mixing impeller mounts, drainage-port geometry and surface-finish claims tied to shear reduction carry comparatively less prior art than working-volume and aspect-ratio claims on the vessel itself. A first claim in these areas would need to tie a specific structural feature — port placement, impeller mount geometry, or finish treatment — to a measurable process outcome to stand apart from the existing geometry-focused filings.

US20130288346A1 discloses a single-use bioreactor bag designed to hold a consistent shear rate at the impeller tip and in the bulk fluid across a range of power-per-volume and rpm settings, paired with a scalable system using two bags at a working-volume height-to-diameter ratio of about 1.5. Claims built this way tend to block designs that rely on the same H/D ratio combined with the same shear-uniformity mechanism for scale-up, rather than blocking every bag using an H/D near 1.5 in isolation. Anyone designing a scalable single-use vessel system should check whether their shear-profile claims or scale-up methodology overlap with this specific combination before finalising a design.